| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | NEUTRAL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 25.57▲ | 25.66▼ | 25.64▼ | 25.45▲ | 29.70▼ |
| MA10 | 25.63▼ | 25.69▼ | 25.70▼ | 25.06▲ | 36.17▼ |
| MA20 | 25.64▼ | 25.51▲ | 25.40▲ | 28.47▼ | 35.87▼ |
| MA50 | 25.66▼ | 25.40▲ | 24.37▲ | 36.95▼ | 30.48▼ |
| MA100 | 25.59▲ | 24.23▲ | 26.74▼ | 35.83▼ | N/A |
| MA200 | 25.35▲ | 27.09▼ | 32.58▼ | 30.92▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.010▼ | -0.018▼ | -0.023▼ | 0.184▲ | -2.167▼ |
| RSI | 47.021▼ | 51.898▲ | 53.180▲ | 36.439▼ | 40.215▼ |
| STOCH | 51.987 | 55.867 | 54.109 | 41.112 | 11.400▼ |
| WILL %R | -50.847 | -61.589 | -46.040 | -59.314 | -84.852▼ |
| CCI | -25.613 | -22.128 | 35.684 | -27.549 | -162.607▼ |
|
Wednesday, November 12, 2025 02:54 AM
Potential LENZ Therapeutics, Inc. ( NASDAQ:LENZ ) shareholders may wish to note that the Co-Founder & Director, ...
|
|
Monday, November 10, 2025 02:03 PM
VIZZTM (aceclidine ophthalmic solution) 1.44% received FDA approval for the treatment of presbyopia Commercial product launch initiated in October 2025 with broad product availability in mid-Q4 2025 ...
|
|
Monday, November 10, 2025 02:02 PM
LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a pharmaceutical company focused on the commercialization of VIZZ™ (aceclidine ophthalmologic solution) 1.44%, the first and only FDA ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/11/25 | 26.00 | 26.225 | 25.02 | 25.60 | 1,053,866 |
| 13/11/25 | 25.32 | 26.54 | 24.51 | 26.49 | 1,501,757 |
| 12/11/25 | 26.43 | 26.81 | 24.51 | 25.50 | 1,259,418 |
| 11/11/25 | 23.40 | 26.6699 | 23.40 | 26.45 | 1,734,823 |
| 10/11/25 | 23.96 | 24.50 | 22.90 | 23.19 | 1,046,411 |
| 07/11/25 | 22.31 | 23.93 | 22.0101 | 22.97 | 1,457,423 |
| 06/11/25 | 22.18 | 23.877 | 22.00 | 22.96 | 2,007,981 |
| 05/11/25 | 25.35 | 26.4899 | 21.21 | 21.47 | 4,051,734 |
| 04/11/25 | 26.93 | 28.40 | 26.79 | 28.05 | 1,169,818 |
| 03/11/25 | 29.64 | 29.64 | 27.10 | 27.93 | 1,498,926 |
|
|
||||
|
|
||||
|
|